NCCN Names Trodelvy a Preferred First-Line Treatment for Metastatic TNBCByCURE staffFebruary 4th 2026
Pelareorep Receives FDA Fast Track Status for KRAS-Mutant Colorectal Cancer ByCURE staffFebruary 4th 2026